Cargando…
Pimobendan in Chronic Right Heart Failure in a Left Ventricular Assist Device Patient
We report the case of a 76-year-old patient who developed chronic right heart failure 1 year after left ventricular assist device implantation due to ischemic cardiomyopathy. Initial recompensation was achieved through dobutamin, sildenafil, and levosimendan treatment. Yet, discharge was successful...
Autores principales: | Kreibich, Maximilian, Berchtold-Herz, Michael, Beyersdorf, Friedhelm, Trummer, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177432/ https://www.ncbi.nlm.nih.gov/pubmed/28018821 http://dx.doi.org/10.1055/s-0036-1571286 |
Ejemplares similares
-
The endogenous thrombin potential in patients with left ventricular assist device or heart transplant
por: Schlagenhauf, Axel, et al.
Publicado: (2023) -
Platelet Secretion Defects and Acquired von Willebrand Syndrome in Patients With Ventricular Assist Devices
por: Geisen, Ulrich, et al.
Publicado: (2018) -
Right heart failure after left ventricular assist device: From mechanisms to treatments
por: Bravo, Claudio A., et al.
Publicado: (2022) -
Predictors of right ventricular failure after left ventricular assist device implantation
por: Koprivanac, Marijan, et al.
Publicado: (2014) -
Left ventricular assist devices and right ventricular failure prediction: Quo Vadis?
por: Lorusso, Roberto, et al.
Publicado: (2021)